Cotinine, a Neuroactive Metabolite of Nicotine: Potential for Treating Disorders of Impaired Cognition
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The pharmacological effects of the tobacco‐derived alkaloid nicotine have been widely studied in humans and animals for decades. However, relatively little attention has been given to the potential actions of its major metabolite, cotinine. After nicotine consumption the duration of cotinine's presence in blood and brain greatly exceeds that of nicotine. Therefore, cotinine could mediate the more protracted pharmacological effects of nicotine. The studies described in this report were thus designed to further investigate certain neuropharmacological actions of cotinine. Behavioral tests (e.g., delayed matching‐to‐sample) were conducted in aged rhesus monkeys to assess the effects of cotinine on working memory and attention. In rats a prepulse inhibition (PPI) procedure was used to assess the effects of the compound on auditory gating — a method for predicting the potential antipsychotic properties of drugs. Cotinine exhibited significant effectiveness in these tasks. The drug was also cytoprotective in differentiated PC‐12 cells with a potency equivalent to that of nicotine. The effects of chronic cotinine treatment on the expression of nicotinic and muscarinic acetylcholine receptors in rat brain were measured by [125 I]epibatidine, [125 I]α‐bungarotoxin ([125 I]BTX), [3 H]pirenzepine ([3 H]PRZ), and [3 H]AFDX‐384 ([3 H]AFX) autoradiography. Unlike nicotine, cotinine failed to upregulate the expression of brain nicotinic receptors. Based on its relative safety in man, cotinine should prove useful in the treatment of diseases of impaired cognition and behavior without exhibiting the toxicity usually attributed to nicotine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Schizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690
J. Vainio, R. K. T. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110043095 · Cited by 51
Cited by
Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models
Schramm-Sapyta, N. L., Walker, Q. D., Caster, J. M., Levin, E. D., & Kuhn, C. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1585-5 · Cited by 215
Desensitization of nicotinic acetylcholine receptors as a strategy for drug development
Buccafusco, J. J., Beach, J. W., & Terry, A. V. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145292 · Cited by 144
Self-citationWhy Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis
Bharate, S. S., Mignani, S., & Vishwakarma, R. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01922 · Cited by 102
Zhu, J., Fan, F., McCarthy, D. M., Zhang, L., Cannon, E. N., Spencer, T. J., Biederman, J., & Bhide, P. G. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.01.014 · Cited by 54
Cotinine selectively activates a subpopulation of α3/α6β2* nicotinic receptors in monkey striatum
O’Leary, K., Parameswaran, N., McIntosh, J. M., & Quik, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136838 · Cited by 45
“Indeed, numerous studies indicate that cotinine influences autonomic functions including heart rate, blood pressure, respiration, and hormone regulation (Borzelleca et al., 1962; Dominiak et al., 1985; Andersson et al., 1993; Buccafusco et al., 2007), and it also affects behavioral and cognitive task performance (Risn…”
Background
Metadata
- Authors
- Terry, A. V., Hernandez, C. M., Hohnadel, E. J., Bouchard, K. P., & Buccafusco, J. J.
- Venue
- CNS Drug Reviews
- Publisher
- Wiley
- Published
- 2005-09
- Volume
- 11
- Issue
- 3
- Pages
- 229-252
- ISSN
- 1080-563X (ISSN-L)
- 1527-3458
- OpenAlex
- W2117585066
- Cited by
- 76
- References
- 3
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cotinine, a Neuroactive Metabolite of Nicotine: Potential for Treating Disorders of Impaired Cognition. https://app.cochat.ai/papers/10.1111/j.1527-3458.2005.tb00045.x
- The paper
- Terry, A. V., Hernandez, C. M., Hohnadel, E. J., Bouchard, K. P., & Buccafusco, J. J. (2005). Cotinine, a Neuroactive Metabolite of Nicotine: Potential for Treating Disorders of Impaired Cognition. CNS Drug Reviews. https://doi.org/10.1111/j.1527-3458.2005.tb00045.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.